Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern Clinical Trials, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), your-feed-healthcare
By BY KATHERINE J. WU AND KATIE THOMAS from NYT Health https://nyti.ms/33Wrajr
The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.